Cohen's SAC Capital Raises Stake in Celldex (CLDX) to 4.9%
Tweet Send to a Friend
In a 13G filing on Celldex Therapeutics, Inc. (NASDAQ: CLDX), Steven A. Cohen's hedge ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
